RESUMO
Using organotypic hippocampal slice cultures we have investigated the actions of Interleukin-1 (IL-1) in a number of injury paradigms. Low concentrations of IL-1 potentiated hypoxia-induced neurodegeneration whilst high concentrations had no effect. In contrast, higher concentrations of IL-1 were strongly neuroprotective in models of combined oxygen/glucose deprivation and N-methyl-D-aspartate toxicity, but no potentiation was observed at low IL-1 concentrations. Both protective and toxic effects of IL-1 were fully antagonized by IL-1 receptor antagonist. These data demonstrate that the effects of IL-1 on neuronal injury are complex, and may be directly related to the injury paradigm studied.
Assuntos
Isquemia Encefálica/metabolismo , Hipocampo/metabolismo , Hipocampo/patologia , Hipóxia/patologia , Interleucina-1/farmacologia , Fármacos Neuroprotetores/farmacologia , Neurotoxinas/farmacologia , Animais , Técnicas de Cultura , Relação Dose-Resposta a Droga , Glucose/deficiência , Hipocampo/efeitos dos fármacos , Hipóxia/complicações , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1/antagonistas & inibidores , N-Metilaspartato/antagonistas & inibidores , N-Metilaspartato/farmacologia , Degeneração Neural/etiologia , Degeneração Neural/patologia , Neurônios/patologia , Fármacos Neuroprotetores/antagonistas & inibidores , Neurotoxinas/antagonistas & inibidores , Concentração Osmolar , Ratos , Ratos Wistar , Sialoglicoproteínas/farmacologiaRESUMO
Inappropriate activation of NMDA receptors during a period of cerebral ischaemia is a crucial event in the pathway leading to neuronal degeneration. However, significant research has failed to deliver a clinically active NMDA receptor antagonist, and competitive NMDA antagonists are ineffective in many experimental models of ischaemia. The NMDA receptor itself has a number of modulatory sites which may affect receptor function under ischaemic conditions. Using rat organotypic hippocampal slice cultures we have investigated whether the redox modulatory site affects the neuroprotective efficacy of NMDA receptor antagonists against excitotoxicity and experimental ischaemia (OGD). NMDA toxicity was significantly enhanced in cultures pretreated with a reducing agent. The noncompetitive antagonist MK-801 and a glycine-site blocker were equally neuroprotective in both normal and reduced conditions, but there was a significant rightward shift in the dose-response curves of the competitive antagonists APV and CPP and the uncompetitive antagonist memantine. OGD produced neuronal damage predominantly in the CA1 region, which was prevented by MK-801 and memantine, but not by APV or CPP. Inclusion of an oxidizing agent during the period of OGD had no effect alone, but significantly enhanced the neuroprotective potency of the competitive antagonists. These data clearly demonstrate that chemical reduction of the redox modulatory site of the NMDA receptor decreases the ability of competitive antagonists to block NMDA receptor-mediated neuronal damage, and that the reducing conditions which occur during simulated ischaemia are sufficient to produce a similar effect. This may have important implications for the design of future neuroprotective agents.
Assuntos
Maleato de Dizocilpina/farmacologia , Hipocampo/fisiologia , Ataque Isquêmico Transitório/fisiopatologia , N-Metilaspartato/toxicidade , Neurônios/fisiologia , Fármacos Neuroprotetores/farmacologia , Receptores de N-Metil-D-Aspartato/fisiologia , 2-Amino-5-fosfonovalerato/farmacologia , Animais , Ácido Ditionitrobenzoico/farmacologia , Ditiotreitol/farmacologia , Antagonistas de Aminoácidos Excitatórios/farmacologia , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Ataque Isquêmico Transitório/patologia , Memantina/farmacologia , Neurônios/efeitos dos fármacos , Neurônios/patologia , Técnicas de Cultura de Órgãos , Piperazinas/farmacologia , Ratos , Ratos Wistar , Receptores de N-Metil-D-Aspartato/antagonistas & inibidoresRESUMO
Upregulation of the pro-inflammatory cytokine tumour necrosis factor-alpha (TNF) occurs rapidly in the brain following ischaemia, although it is unclear whether this represents a neurotoxic or neuroprotective response. We have investigated whether TNF has different actions in the pre- and postischaemic periods in a tissue culture model of cerebral ischaemia. Organotypic hippocampal slice cultures were prepared from 8-10-day-old rats and maintained in vitro for 14 days. Neuronal damage was induced by either 1 h oxygen-glucose deprivation or 3 h exposure to NMDA or the superoxide generator duroquinone, and assessed after 24 h by propidium iodide fluorescence. TNF pretreatment was neuroprotective against both oxygen-glucose deprivation and duroquinone. This effect was associated with an activation of the transcription factor NFkappaB and upregulation of manganese superoxide dismutase, and was prevented by a free radical scavenger. When addition of TNF was delayed until the postinsult period, an exacerbation of neurotoxicity occurred, which was also prevented by a free radical scavenger. The actions of TNF are determined by whether TNF is present before or after an ischaemia-related insult. Both actions are mediated through the production of free radicals, and the response to TNF is determined by whether a cell is metabolically competent to respond by synthesis of antioxidant defences.
Assuntos
Ataque Isquêmico Transitório/fisiopatologia , N-Metilaspartato/toxicidade , Neurônios/efeitos dos fármacos , Fator de Necrose Tumoral alfa/farmacologia , Animais , Benzoquinonas/farmacologia , Morte Celular , Sequestradores de Radicais Livres/farmacologia , Ataque Isquêmico Transitório/patologia , NF-kappa B/metabolismo , Neurônios/patologia , Neurônios/fisiologia , Técnicas de Cultura de Órgãos , Ratos , Ratos Wistar , Receptores de Glutamato/fisiologia , Superóxido Dismutase/genética , Superóxidos/toxicidade , Fatores de TempoRESUMO
Experimental data indicate that NMDA receptor activation is strongly implicated in the pathogenesis of cerebral ischaemia. However, the results from in vivo studies are equivocal, with NMDA antagonists being active in only some models. It has recently been demonstrated that competitive and non-competitive NMDA antagonists behave differently under normal and ischaemic conditions. These studies have used organotypic hippocampal slice cultures to investigate whether this disparity is due to redox-modulation of the NMDA receptor which occurs in ischaemia. NMDA-mediated toxicity was concentration dependent with little damage occurring with less than 10 microM NMDA and maximal damage produced by 30 microM. NMDA toxicity was significantly enhanced by pre-treatment with 1 mM dithiothreitol, a reducing agent, such that damage occurred at 1 nM NMDA, and maximal damage was produced by 10 microM. The efficacy of MK-801 was not altered by reducing conditions, but the EC50 of the competitive antagonist APV was increased by 20-fold. These data strongly suggest that the neuroprotective efficacy of NMDA antagonists is significantly altered under ischaemic conditions, and that more beneficial effects will be obtained with antagonists having a higher affinity for the receptor in the reduced configuration.
Assuntos
Edema Encefálico/fisiopatologia , Isquemia Encefálica/fisiopatologia , Hipocampo/fisiopatologia , N-Metilaspartato/antagonistas & inibidores , N-Metilaspartato/fisiologia , Fármacos Neuroprotetores/farmacologia , Animais , Edema Encefálico/patologia , Isquemia Encefálica/patologia , Técnicas de Cultura , Relação Dose-Resposta a Droga , Hipocampo/patologia , Ratos , Ratos WistarRESUMO
In vivo, preconditioning with a sublethal insult can confer resistance to normally lethal episodes of cerebral ischaemia. This phenomenon has been linked with the induction of the 72 kDa heat shock protein (HSP72), but this has not been clearly demonstrated in vitro. We have used organotypic hippocampal slice cultures to investigate whether tolerance to lethal ischaemia is dependent on HSP72. Cultures were maintained in vitro for 14 days, and neuronal damage assessed using propidium iodide fluorescence. Prolonged neuronal HSP72 upregulation occurred following exposure to 30 min ischaemia, 45 min hypoxia and 1 microM kainate, but not 1 microM NMDA or 20 min ischaemia, all sublethal insults. Preconditioning with ischaemia, kainate or hypoxia 24 h prior to lethal ischaemia (45 min) was not protective, and when the delay was increased to 48 h, damage in the CA3 pyramidal cell region was significantly increased compared to cultures exposed to 45 min ischaemia alone. Preconditioning with 20 min ischaemia had no effect on the severity of ischaemic damage. Preconditioning with 1 microM NMDA significantly reduced neuronal damage produced by either 45 or 60 min ischaemia when the delay between insults was 48 h. NMDA pre-treatment also prevented neurotoxicity produced by glutamate (5-10 mM) but not NMDA (10-30 microM). These data suggest that in vitro, the increased expression of HSP72 following some sublethal insults should be considered as a marker of cell stress prejudicial to the survival of neurones subsequently exposed to ischaemia, while tolerance can be produced through mechanisms independent of HSP72 induction.
Assuntos
Isquemia Encefálica/metabolismo , Proteínas de Choque Térmico/biossíntese , Hipocampo/metabolismo , Precondicionamento Isquêmico , Animais , Agonistas de Aminoácidos Excitatórios/toxicidade , Ácido Glutâmico/toxicidade , Proteínas de Choque Térmico HSP72 , Proteínas de Choque Térmico/análise , Hipocampo/química , Hipocampo/citologia , Ácido Caínico/toxicidade , N-Metilaspartato/toxicidade , Degeneração Neural/induzido quimicamente , Degeneração Neural/metabolismo , Neurotoxinas/metabolismo , Técnicas de Cultura de Órgãos , Ratos , Ratos Wistar , Receptores de N-Metil-D-Aspartato/fisiologiaRESUMO
The benzodiazepine receptor inverse agonist has been shown to produce agonist-like effects at low concentrations. RU34347 has both inverse agonist (attenuation of GABA-responses) and agonist-like (reduction of spontaneous Purkinje cell firing rate) in the cerebellar slice preparation. The benzodiazepine antagonist flumazenil prevented the inverse agonist actions, but only partially reduced the agonist-like effects. Further, brief application of RU34347 to slices mimicked the response to GABA, and pharmacological investigation determined that this action was mediated through increased GABA through action at a site proximal to the parallel fiber-basket cell synapse, at an as yet undetermined receptor.
Assuntos
Moduladores GABAérgicos/farmacologia , Agonistas de Receptores de GABA-A , Imidazóis/farmacologia , Células de Purkinje/efeitos dos fármacos , Pirimidinas/farmacologia , Transmissão Sináptica/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologia , Animais , Cerebelo/efeitos dos fármacos , Flumazenil/farmacologia , Masculino , Ratos , Ratos WistarRESUMO
The phenomenon of induced tolerance to a normally lethal episode of ischaemia by preconditioning with sub-lethal ischaemia has been linked to induction of the 72 kDa heat-shock protein (HSP72). However, a direct correlation between HSP72 expression and ischaemic preconditioning in vivo has not been proven. Using an in vitro model of ischaemia-related neuronal damage we have investigated whether HSP72 protein expression is temporally correlated with subsequent tolerance to a normally lethal ischaemic episode. Organotypic hippocampal slice cultures were maintained in vitro for 14 days before being exposed to hypoxia for 15-180 min. Periods of hypoxia shorter than 60 min did not produce neuronal damage. No HSP72 immunoreactivity was observed in either untreated cultures or in those exposed to hypoxia for 15 min. Following 30 and 45 min hypoxia a significant induction of HSP72 occurred in neurons of both the CA1 and CA3/4 regions of the pyramidal cell layer. A significant number of microglia were positively stained with HSP72. The peak of HSP72 expression occurred 18 h after the induction of hypoxia but remained significantly elevated for 48 h post-hypoxia. Prolonged hypoxia (60 or 180 min) produced a selective lesion of the CA1 pyramidal cell layer which was not associated with an induction of HSP72. Pre-conditioning with 45 min hypoxia 18 h prior to 180 min hypoxia did not reduce the neuronal damage associated with 180 min hypoxia alone. These data strongly suggest that HSP72 does not directly confer tolerance in this in vitro model of ischaemia-related neuronal death.
Assuntos
Proteínas de Choque Térmico/biossíntese , Hipocampo/metabolismo , Hipóxia Encefálica/metabolismo , Animais , Morte Celular , Proteínas de Choque Térmico HSP72 , Imuno-Histoquímica , Precondicionamento Isquêmico , Técnicas de Cultura de Órgãos , Ratos , Ratos WistarRESUMO
The relative roles of the superoxide and hydroxyl radicals in oxidative stress-induced neuronal damage were investigated using organotypic hippocampal slice cultures. Cultures exposed to 100 microM duroquinone, a superoxide-generating compound, for 3 h developed CA1-selective lesions over a period of 24 h. The damage accounted for approximately 64% of the CA1 subfield, whereas CA3 showed just 6% damage, a pattern of damage comparable to that observed following hypoxia/ischaemia. Duroquinone-induced damage was attenuated by a spin-trap agent. In contrast, hydroxyl radical-mediated damage, generated by exposure to 30 microM ferrous sulphate for 1 h, resulted in a CA3-dominant lesion. The damage developed over 24 h, similar to that observed with duroquinone, but with approximately 45% damage in CA3 compared with only 7% in CA1. These data demonstrate a selective vulnerability of the CA1 pyramidal neurones to superoxide-induced damage and suggest that of the free radicals generated following hypoxia/ischaemia, superoxide, rather than hydroxyl radical, is instrumental in producing neuronal damage.
Assuntos
Hipocampo/efeitos dos fármacos , Radical Hidroxila/farmacologia , Estresse Oxidativo , Superóxidos/farmacologia , Animais , Benzenossulfonatos/farmacologia , Benzoquinonas/farmacologia , Isquemia Encefálica , Morte Celular , Compostos Ferrosos/farmacologia , Hipóxia Encefálica , Neurônios/efeitos dos fármacos , Técnicas de Cultura de Órgãos , Ratos , Ratos WistarRESUMO
We have investigated the relative contributions of oxygen and glucose deprivation to ischaemic neurodegeneration in organotypic hippocampal slice cultures. Cultures prepared from 10-day-old rats were maintained in vitro for 14 days and then deprived of either oxygen (hypoxia), glucose (hypoglycaemia), or both oxygen and glucose (ischaemia). Hypoxia alone induced degeneration selectively in CA1 pyramidal cells and this was greatly potentiated if glucose was removed from the medium. We have also characterised the effects of both pre- and post-treatment using glutamate receptor antagonists and the sodium channel blocker tetrodotoxin (TTX). Neuronal death following either hypoxia or ischaemia was prevented by pre-incubation with CNQX, MK-801 or tetrodotoxin. MK-801 or CNQX also prevented death induced by either hypoxia or ischaemia if added immediately post-insult, however, post-insult addition of TTX prevented hypoxic but not ischaemic damage. Organotypic hippocampal slice cultures are sensitive to both NMDA and non-NMDA glutamate receptor blockade and thus represent a useful in vitro system for the study of ischaemic neurodegeneration paralleling results reported using in vivo models of ischaemia.
Assuntos
Isquemia Encefálica/tratamento farmacológico , Antagonistas de Aminoácidos Excitatórios/farmacologia , Hipocampo/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , 6-Ciano-7-nitroquinoxalina-2,3-diona/farmacologia , Animais , Isquemia Encefálica/patologia , Morte Celular/efeitos dos fármacos , Hipocampo/irrigação sanguínea , Hipoglicemia/tratamento farmacológico , Hipoglicemia/patologia , Hipóxia Encefálica/tratamento farmacológico , Hipóxia Encefálica/patologia , Neurônios/patologia , Técnicas de Cultura de Órgãos , Ratos , Ratos Wistar , Receptores de AMPA/antagonistas & inibidores , Canais de Sódio/efeitos dos fármacosRESUMO
BACKGROUND AND PURPOSE: Neuroprotection by antagonists of both L-type and N-type calcium channels occurs in in vivo models of ischemia. The site of action of calcium channel antagonists is unclear, however, and it is likely that a combination of vascular and direct neuronal actions occurs. We have investigated the effects of blocking neuronal calcium channels using an organotypic hippocampal-slice model of ischemia. METHODS: Organotypic hippocampal-slice cultures prepared from 10-day-old rats were maintained in vitro for 14 days. Cultures were exposed to either 3 hours of oxygen deprivation (hypoxia) or 1 hour of combined oxygen and glucose deprivation (ischemia). Neuronal damage was quantified after 24 hours by propidium iodide fluorescence. RESULTS: Three hours of anoxia produced damage exclusively in CAT pyramidal cells. This damage was prevented by preincubation with omega conotoxin MVIIA, a selective N-type calcium channel blocker, and omega conotoxin MVIIC, which blocks N-type and other presynaptic neuronal calcium channels. The dihydropyridine nifedipine and the mixed calcium channel blocker SB201823-A were not protective. Furthermore, if addition of conotoxin MVIIA was delayed until after the hypoxic episode, a dose-dependent neuroprotective effect was observed, with an IC50 of 50 nmol/L. In contrast to hypoxia, none of the compounds was neuroprotective in the model of oxygen-glucose deprivation, although it was determined that extracellular calcium was essential for the generation of ischemic damage. CONCLUSIONS: These studies present clear evidence that neuroprotection by selective N-type calcium channel antagonists is mediated directly through neuronal calcium channels. In contrast, the neuroprotective effects of dihydropyridines may be mediated through vascular calcium channels or indirectly through actions in other brain regions.
Assuntos
Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Hipocampo/fisiopatologia , Hipóxia/patologia , Hipóxia/prevenção & controle , Fármacos Neuroprotetores/farmacologia , Peptídeos/farmacologia , ômega-Conotoxinas , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Hipocampo/citologia , Hipóxia/fisiopatologia , Ratos , Ratos Wistar , Fatores de TempoRESUMO
We have investigated the neuroprotective actions of neurotrophins in a model of ischaemia using slice cultures. Ischaemia was induced in organotypic hippocampal cultures by simultaneous oxygen and glucose deprivation. Cell death was assessed 24 h later by propidium iodide fluorescence. Pre- but not post-ischaemic addition of brain-derived neurotrophic factor (BDNF) produced a concentration-dependent reduction in neuronal damage. Neurotrophin-3 was not neuroprotective. These data suggest that BDNF may form part of an endogenous neuroprotective mechanism.
Assuntos
Isquemia Encefálica/tratamento farmacológico , Fator Neurotrófico Derivado do Encéfalo/farmacologia , Morte Celular/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Fatores de Crescimento Neural/farmacologia , Animais , Relação Dose-Resposta a Droga , Ratos , Ratos WistarRESUMO
We have characterised the biphasic response of the benzodiazepine receptor inverse agonist RU34347 in the rat cerebellar slice preparation using extracellular electrophysiological recordings from Purkinje cells. RU34347 (10 fM-10 nM) produced an increase in GABA(A)-mediated inhibition at between 10 fM and 10 nM, a response normally associated with benzodiazepine agonists. This response was biphasic, being dose dependent between 10 fM and the peak effect at 10 pM, and inversely related to concentration between 100 pM and 10 nM. Associated with this increase in inhibition was a decrease in firing rate, also showing a biphasic concentration-response relationship. The agonist-like response was composed of two elements, an initial increase occurring after 5 min followed by a slow decline over the next 20 min. This second, declining, phase was more evident at higher concentrations of RU34347. The peak effect seen at 10 pM was fully antagonised by 1 microM flumazenil, a benzodiazepine receptor antagonist. This concentration of flumazenil also antagonised the decrease in firing rate induced by 10 pM RU34347. The response to 10 nM RU34347 was further characterised since the largest second phase decline was demonstrated at this concentration. 10 nM flumazenil fully antagonised the second, declining, phase of the response, but not the magnitude of the initial increase. A partial antagonism of the peak effect was seen with 1 microM flumazenil, and a full antagonism at 10 microM flumazenil. This effect was similar to that observed with Ro15-4513 in a previous study. Therefore, we investigated the binding of RU34347 to diazepam-insensitive benzodiazepine receptors. [3H]Ro15-4513 was displaced by Ro15-4513, flumazenil and Ro19-4603, but not by RU34347. Therefore, although the electrophysiological data correlate well with that previously reported for Ro15-4513, RU34347 does not displace Ro15-4513 binding at the diazepam-insensitive benzodiazepine receptor. Therefore, either both ligands bind to complimentary sites on the same receptor complex, or both induce a similar physiological response through an action on different receptors.
Assuntos
Cerebelo/metabolismo , Agonistas de Receptores de GABA-A , Imidazóis/farmacologia , Pirimidinas/farmacologia , Animais , Cerebelo/efeitos dos fármacos , Flumazenil/farmacologia , Moduladores GABAérgicos/farmacologia , Técnicas In Vitro , Masculino , Células de Purkinje/efeitos dos fármacos , Ensaio Radioligante , Ratos , Ratos WistarRESUMO
Recently, a role of IL-1 in the central nervous system has been described, principally a fever-inducing effect in the hypothalamus through a prostaglandin second messenger system. IL-1 has also been shown to potentiate gamma-aminobutyric acid (GABAA) responses in embryonic chick neurones. This study describes the investigation of the effect of IL-1 on GABAA responses within the in vitro rat cerebellar slice, a preparation containing intact neuronal circuitry. Stimulation of the area of passage of paralleled fibres produced a pure GABAA inhibition of the spontaneous firing of Purkinje cells. 5 and 10 ng/ml IL-1 produced a reduction in the duration of inhibition 10 min after beginning perfusion of IL-1. This effect reversed within 15 min of washing out the IL-1. 10 ng/ml IL-1 also reduced the effects of exogenously-applied GABA (0.1 mM) with the same time course. In the presence of 1 uM indomethacin, there was no change in the effect of the IL-1. It can therefore be concluded that the reduction in cerebellar GABAA responses by IL-1 is not mediated by the indomethacin-sensitive prostaglandin second messenger system.
Assuntos
Cerebelo/efeitos dos fármacos , Interleucina-1/farmacologia , Células de Purkinje/efeitos dos fármacos , Receptores de GABA-A/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologia , Animais , Cerebelo/fisiologia , Inibidores de Ciclo-Oxigenase/farmacologia , Eletrofisiologia , Técnicas In Vitro , Indometacina/farmacologia , Masculino , Células de Purkinje/fisiologia , Ratos , Ratos Wistar , Receptores de GABA-A/fisiologiaRESUMO
Modulation of GABA-mediated neurotransmissions by Ro 15-4513 in cerebellar slices was assessed following stimulation of the parallel fibre input, which, in this preparation, preferentially activates the inhibitory interneurones innervating Purkinje cells. Peristimulus-time histogram analysis of inhibitory responses of spontaneously-active Purkinje cells showed only a decrease in the duration of inhibition induced by Ro 19-4603. This is consistent with inverse agonism on the BZ1 receptors associated with postsynaptic GABAA receptors on Purkinje cells. 1 microM Ro 15-4513 induced a similar response but 100 nM Ro 15-4513 induced a biphasic response, with an increase in duration of inhibition preceding the decrease during continued perfusion of the compound. At lower concentrations of Ro 15-4513 the increase in inhibition predominated, the minimal effective concentration being 10 pM. 1 microM flumazenil blocked both components of this response to 100 nM Ro 15-4513, but at 100 nM flumazenil only blocked the decrease in inhibition. The ability of Ro 15-4513 but not Ro 19-4603 to enhance inhibition and its relative insensitivity to 100 nM flumazenil, parallel the affinities of these compounds for diazepam-insensitive (DI) binding sites in the cerebellum. These data suggest that the enhancement of inhibition induced by Ro 15-4513 results from its inverse agonist activity on DI receptors causing disinhibition of both granule cells and their parallel fibres and increased sensitivity to the electrical stimuli inducing activation of the inhibitory interneurones innervating Purkinje cells.
Assuntos
Azepinas/farmacologia , Azidas/farmacologia , Benzodiazepinas/farmacologia , Células de Purkinje/efeitos dos fármacos , Sinapses/efeitos dos fármacos , Animais , Azidas/antagonistas & inibidores , Benzodiazepinas/antagonistas & inibidores , Cerebelo/citologia , Cerebelo/efeitos dos fármacos , Diazepam/farmacologia , Eletrofisiologia , Flumazenil/farmacologia , Técnicas In Vitro , Masculino , Inibição Neural/efeitos dos fármacos , Células de Purkinje/fisiologia , Ratos , Ratos Wistar , Receptores de GABA-A/efeitos dos fármacosRESUMO
The effects of systemic administration of the GABAB agonist, baclofen was investigated on food intake in non-fasted rats. Baclofen (1.0, 2.0 and 4.0 mg/kg, s.c.) produced a dose-related increase in food intake in a free-feeding paradigm during the first 90 min after administration, with maximum increases occurring at a dose of 2 mg/kg (Experiment 1). Baclofen (0.5 and 1.0 mg/kg, s.c.) also increased food intake in the 40 min post-drug recording period in non-fasted rats, trained to make operant responses for food on a fixed-ratio schedule (Experiment 2). These results demonstrate that systemic administration of baclofen can stimulate ingestive behaviour in satiated rats and suggest a possible role for a GABAB receptor-mediated mechanism in the control of food intake.